Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Prostate Cancer and Prostatic Diseases|September 8, 2010
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrenceD Hawksworth, L Ravindranath, Y Chen, et al.Journal of Clinical Pathology|June 17, 2008
Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?B Furusato, I L Rosner, D Osborn, et al.Prostate Cancer and Prostatic Diseases|July 15, 2009
Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion statusK Mwamukonda, Y Chen, L Ravindranath, et al.Prostate Cancer and Prostatic Diseases|October 19, 2005
Quantitative expression profile of PSGR in prostate cancerL L Xu, C Sun, G Petrovics, et al.Prostate Cancer and Prostatic Diseases|September 5, 2007
Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimensB Furusato, S Shaheduzzaman, G Petrovics, et al.Prostate Cancer and Prostatic Diseases|June 30, 2010
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratificationB Furusato, S-H Tan, D Young, et al.Prostate Cancer and Prostatic Diseases|February 21, 2012
Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progressionC A Derosa, B Furusato, S Shaheduzzaman, et al.Oncogene|June 11, 2008
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiationC Sun, A Dobi, A Mohamed, et al.Pageof 1